Collective Voice is pleased to announce the appointment of Oliver Standing as its new Director.
Oliver is currently Director of Policy and Communications at Adfam, the national charity for families affected by drugs and alcohol. He will join the organisation in mid-August and succeed Paul Hayes who has been Collective Voice’s Chief Executive since its inception in 2015.
Karen Biggs, Chair of Collective Voice, said
“I am delighted to welcome Oliver to Collective Voice. He impressed the panel with his passion for the work the sector does. The Board is looking forward to working with Oliver, building on the significant achievements made over the last three years under the expert leadership of Paul Hayes.”
Oliver Standing said
“It’s a real honour to be appointed Collective Voice’s next Director. I’ve been impressed by the progress the organisation has made so far. I look forward to working closely with Karen and the rest of the Board to broaden Collective Voice’s reach and advocate for, and alongside, some of our most vulnerable citizens. Paul will leave big shoes to fill but I’ll enjoy learning from him over the coming months as we work together to ensure a smooth transition.”
Collective Voice is the membership organisation for voluntary sector drug and alcohol treatment providers. Together, its members offer a range of services to over 200,000 people across the country. The current members are Blenheim, CGL, Changing Lives, Cranstoun, DISC, EDP Drug and Alcohol Services, Phoenix Futures and Turning Point. Its Board is comprised of Chief Executive and other senior staff from the membership.
Related Content
Drug and alcohol treatment funding for 2024/25
Drug and alcohol treatment funding for 24/25 has been announced in sufficient time for planning next year’s services. However we are concerned that some areas
Collective Voice responds to the ACMD on Drug Use in Ethnic Minority Groups
Read our submission The Advisory Council on the Misuse of Drugs (ACMD) has issued a call for evidence around drug use in ethnic minority groups.
National Audit Office report highlights need to build upon the Drug Strategy and develop a long term, funded plan for full delivery.
Read the report “The government will only achieve value for money if it builds on the initial momentum of the new strategy and develops a